Neuro | Tincture | THCa, CBD & CBGa | 2600mg | 30ml

Anti-Spasmodic and Muscle Support

THCa and CBD may support anti-spasmodic activity through their modulation of CB1 and CB2 receptors within the endocannabinoid system. CB1 receptors in the brain and spinal cord regulate neurotransmitter release, preventing excessive neuronal activity that drives involuntary muscle contractions. CBD acts as a non-competitive allosteric antagonist on these receptors, crossing the blood–brain barrier to exert central analgesic and anti-inflammatory effects — including the reduction of TNF-α, a pro-inflammatory cytokine implicated in inflammation-driven spasticity. THCa, as the non-psychotropic acidic precursor, is well-tolerated and may complement CBD's actions within this system.

Breakthrough Antimicrobial Activity

CBGA exhibits potent broad-spectrum antimicrobial properties, including activity against drug-resistant MRSA with unique membrane-targeting mechanisms.

Neuro Protection

THCA acts as a powerful PPARγ agonist, boosting mitochondrial health and cellular energy production to protect neurons from damage and support long-term brain resilience.

Neuroplasticity and Cognitive Support

In preclinical Alzheimer’s‑like models, THCA restored hippocampal BDNF (brain‑derived neurotrophic factor) and CREB (cAMP response element–binding protein) signalling and improved learning and memory, suggesting potential support for neuroplasticity and cognitive function; human studies are still needed.

Possible Alzheimer's Support

Preclinical research shows that THCA reduces Alzheimer’s‑related pathology markers (hippocampal amyloid‑beta and phosphorylated tau) and improves memory performance, as measured by spatial learning and object recognition tests; human studies are still needed.

Potential Anti-Fibrosis Effects

CBGA provides the most potent TRPM7 ion channel suppression among all cannabinoids, suggesting superior neuroprotection and anti-fibrosis effects.